Are you a print subscriber? Activate your account. By Tim Nudd - 1 hour 14 min ago By Adrianne Pasquarelli - 5 hours 42 min ago By Erika Wheless - 5 hours 42 min ago By Brian Bonilla - 5 hours 42 ...

There's some rumbling going on within Pfizer's investment community, as an activist hedge fund says that the company's performance has not been good enough. Pfizer has been in an anomalous ...

Despite that underperformance over the past 2 months, I believe Pfizer stock still deserves its "Buy" rating. In my opinion, the company is likely to exceed the third-quarter 2024 consensus ...

Pfizer PFE will report its third-quarter 2024 earnings on Oct. 29, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $15.19 billion and 64 cents per share ...

The U.S. is entering the second RSV season in which vaccines for the virus are available for older adults. Yet, despite three options on the market from Pfizer, GSK and Moderna, uptake has been slow ...

That’s not what happened at the beginning of a recent campaign led by the hedge fund Starboard Value against pharmaceutical giant Pfizer. The FT’s Oliver Barnes, US pharmaceutical and biotech ...

The Food and Drug Administration expanded its approval of Pfizer’s vaccine for a deadly respiratory virus to a new age group. The vaccine, called Abrysvo, has been approved for the prevention of ...

Oct 22 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Pfizer's (PFE.N), opens new tab RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in ...

Pfizer has told 75 employees in Sanford, North Carolina, that their positions have been eliminated. The layoffs come three months after the company axed 150 positions in Sanford following a high ...

NEW YORK, Oct 22 (Reuters) - Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's (PFE.N), opens new tab board needs to hold management accountable ...

Activist hedge fund manager Jeff Smith outlined his concerns about drugmaker Pfizer on Tuesday but stopped short of offering a solution — saying that's a job for the board of directors.

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job. Starboard has called on Pfizer’s board to “hold management ...